Analytica Chimica Acta, Год журнала: 2024, Номер 1338, С. 343551 - 343551
Опубликована: Дек. 15, 2024
Язык: Английский
Analytica Chimica Acta, Год журнала: 2024, Номер 1338, С. 343551 - 343551
Опубликована: Дек. 15, 2024
Язык: Английский
SLAS TECHNOLOGY, Год журнала: 2025, Номер unknown, С. 100245 - 100245
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
1Biochemistry, Год журнала: 2025, Номер unknown
Опубликована: Март 25, 2025
RNA presents abundant opportunities as a drug target, offering significant potential for small molecule medicine development. The transcriptome, comprising both coding and noncoding RNAs, is rich area therapeutic innovation, yet challenges persist in targeting with molecules. structure can be predicted or without experimental data, but discrepancies the actual biological impede progress. Prioritizing targets supported by genetic evolutionary evidence enhances success. Further, molecules must demonstrate binding to cells, not solely vitro, validate target compound. Effective binders modulate functional sites that influence biology, nonfunctional requires recruiting effector mechanisms, example degradation, achieve outcomes. Addressing these critical unlocking RNA's vast medicines, strategic framework proposed navigate this promising field, focus on human RNAs.
Язык: Английский
Процитировано
0European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 292, С. 117695 - 117695
Опубликована: Апрель 25, 2025
Язык: Английский
Процитировано
0Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown
Опубликована: Июнь 4, 2025
In target-based drug discovery, quantification of target engagement is required to build structure-activity relationships and develop a potent clinical candidate. Target data also provides evidence drug's mechanism action (MoA) which although not for approval, can increase the chance successful outcome. Consequently, plethora assays has been developed provide information about on isolated proteins in cells. These techniques monitor changes stability, structure, optical properties or mass difference between their complexes with ligands. They characterization compound thermodynamic, kinetic structural binding parameters. The diversity approaches reflects challenges faced when drugging different protein classes, each method having advantages, trade-offs specificity.
Язык: Английский
Процитировано
0Journal of Medicinal Chemistry, Год журнала: 2024, Номер 67(17), С. 15862 - 15872
Опубликована: Авг. 20, 2024
Carbonic anhydrases (CAs) are a family of enzymes that play an important pH regulatory role in health and disease. While different CA isozymes have high degree structural similarity, they variable enzymatic activity, with III being the least active having less than 1% activity II, most active. Furthermore, ligand binding studies for limited, resulting lack chemical probes impedes understanding this isozyme comparison to other members where abundant. Therefore, we employed native mass spectrometry (nMS), also known as intact spectrometry, assess II discovered two novel compounds first time display strong III. We present new data visualization quantification tool developed spectra intuitive stacked heat map representation rapidly interpreting results ligand-protein from nMS screening.
Язык: Английский
Процитировано
0Analytica Chimica Acta, Год журнала: 2024, Номер 1338, С. 343551 - 343551
Опубликована: Дек. 15, 2024
Язык: Английский
Процитировано
0